People under 40 in Britain will be offered an alternative to the Oxford/AstraZeneca vaccine where possible and while infection rates remain low, following a recommendation from government advisers. The Joint Committee on Vaccination and Immunisation (JCVI) reviewed the speed and uptake of Covid vaccines in the UK and the latest figures on very rare blood clots after first shots of the AstraZeneca vaccine
This content first appear on the guardian